Preparation of levofloxacin loaded in situ gel for sustained ocular delivery: in vitro and ex vivo evaluations
- PMID: 31818154
- DOI: 10.1080/03639045.2019.1698598
Preparation of levofloxacin loaded in situ gel for sustained ocular delivery: in vitro and ex vivo evaluations
Abstract
The major drawback of the eye drops is rapid elimination of drug from the precorneal region, thus ensuing poor bioavailability as well as therapeutic efficacy. To conquer these limitations, a pH triggered in situ gel was developed for sustained delivery of levofloxacin. Two polymers namely hydroxypropyl methylcellulose (HPMC) and sodium alginate along with the boric acid buffer were used to formulate the in situ gel. Based on the various physicochemical evaluation parameters like pH, clarity and gelling capacity placebo formulations were selected and further characterized for viscosity, in vitro release, ex vivo corneal permeation, and histopathological studies. The optimized in situ gel (F28) showed sustained release of 93 ± 4.23% for 24 h and cumulative drug permeation of 71.81 ± 4.7% for 72 h. Additionally, ocular irritation study and histopathology of the formulation treated cornea confirm the non-irritancy of the optimized formulation. Based on all the above performed studies, it can be concluded that the in situ gel would present a fruitful alternative for the ocular infections.
Keywords: Eye drops; corneal permeation; gelling system; in situ gel; polymer.
Similar articles
-
Development and evaluation of a novel in situ gel of sparfloxacin for sustained ocular drug delivery: in vitro and ex vivo characterization.Pharm Dev Technol. 2015;20(6):662-9. doi: 10.3109/10837450.2014.910807. Epub 2014 Apr 23. Pharm Dev Technol. 2015. PMID: 24754411
-
Terminalia arjuna gum/alginate in situ gel system with prolonged retention time for ophthalmic drug delivery.Int J Biol Macromol. 2020 Jun 1;152:1056-1067. doi: 10.1016/j.ijbiomac.2019.10.193. Epub 2019 Nov 18. Int J Biol Macromol. 2020. PMID: 31751751
-
Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system.Drug Deliv. 2007 Nov;14(8):507-15. doi: 10.1080/10717540701606426. Drug Deliv. 2007. PMID: 18027180
-
Hydroxypropyl methylcellulose: Physicochemical properties and ocular drug delivery formulations.Eur J Pharm Sci. 2021 Apr 1;159:105736. doi: 10.1016/j.ejps.2021.105736. Epub 2021 Jan 28. Eur J Pharm Sci. 2021. PMID: 33516807 Review.
-
Polysaccharide as renewable responsive biopolymer for in situ gel in the delivery of drug through ocular route.Int J Biol Macromol. 2020 May 1;150:559-572. doi: 10.1016/j.ijbiomac.2020.02.097. Epub 2020 Feb 11. Int J Biol Macromol. 2020. PMID: 32057864 Review.
Cited by
-
The Emerging Role of Topical Ocular Drugs to Target the Posterior Eye.Ophthalmol Ther. 2021 Sep;10(3):465-494. doi: 10.1007/s40123-021-00365-y. Epub 2021 Jul 4. Ophthalmol Ther. 2021. PMID: 34218424 Free PMC article. Review.
-
Breaking Barriers in Eye Treatment: Polymeric Nano-Based Drug-Delivery System for Anterior Segment Diseases and Glaucoma.Polymers (Basel). 2023 Mar 9;15(6):1373. doi: 10.3390/polym15061373. Polymers (Basel). 2023. PMID: 36987154 Free PMC article. Review.
-
The Use of Polymer Blends in the Treatment of Ocular Diseases.Pharmaceutics. 2022 Jul 7;14(7):1431. doi: 10.3390/pharmaceutics14071431. Pharmaceutics. 2022. PMID: 35890326 Free PMC article. Review.
-
Formulation and Development of Nanofiber-Based Ophthalmic Insert for the Treatment of Bacterial Conjunctivitis.Int J Mol Sci. 2024 Aug 25;25(17):9228. doi: 10.3390/ijms25179228. Int J Mol Sci. 2024. PMID: 39273175 Free PMC article.
-
Development of ion-triggered in situ gel containing ketoconazole/hydroxypropyl-β-cyclodextrin for ocular delivery: in vitro and in vivo evaluation.Drug Deliv. 2024 Dec;31(1):2424217. doi: 10.1080/10717544.2024.2424217. Epub 2024 Nov 12. Drug Deliv. 2024. PMID: 39533742 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
